Drugplain

Mucus Relief DM Maximum Strength 20 mg/20mL

Dextromethorphan HBr, Guaifenesin · LIQUID · Cardinal Health (Leader) 70000

No Recall History
Plain English

Mucus Relief DM Maximum Strength is an over-the-counter liquid medication that combines dextromethorphan (a cough suppressant) and guaifenesin (an expectorant) to help relieve cough and loosen mucus. It is taken by mouth and is commonly used to manage cough and congestion associated with colds and other respiratory conditions.

Key Facts

Brand Name
Mucus Relief DM Maximum Strength
Generic Name
Dextromethorphan HBr, Guaifenesin
NDC Code (Product)
70000-0565
Manufacturer
Cardinal Health (Leader) 70000
Strength
20 mg/20mL
Dosage Form
LIQUID
Route
ORAL
Marketing Status
Application #
M012
Drug Class
Expectorant [EPC]
Marketing Start
04/30/2020

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

covid-1910 reports
dyspnoea9 reports
disease recurrence7 reports
pain7 reports
asthenia6 reports
diarrhoea6 reports
pneumonia6 reports
cardiac arrest5 reports
cough5 reports
dehydration5 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get to sleep

Dosage & Administration

Directions do not take more than 6 doses in any 24-hour period measure only with dosing cup provided do not use dosing cup with other products dose as follows or as directed by a doctor mL = milliliter adults and children 12 years and older: 20 mL every 4 hours children under 12 years of age: Do not use

Warnings

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or emphysema cough that occurs with too much phlegm (mucus) When using this product do not use more than directed Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash or persistent headache that lasts. These could be signs of a serious condition. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-2222.

Frequently Asked Questions

What is Mucus Relief DM Maximum Strength used for?

Mucus Relief DM Maximum Strength is an over-the-counter liquid medication that combines dextromethorphan (a cough suppressant) and guaifenesin (an expectorant) to help relieve cough and loosen mucus. It is taken by mouth and is commonly used to manage cough and congestion associated with colds and other respiratory conditions.

Is Mucus Relief DM Maximum Strength a controlled substance?

Mucus Relief DM Maximum Strength is not classified as a controlled substance by the DEA.

What is the generic name for Mucus Relief DM Maximum Strength?

The generic name for Mucus Relief DM Maximum Strength is Dextromethorphan HBr, Guaifenesin. There are 12 other brand versions of Dextromethorphan HBr, Guaifenesin.

What is the NDC code for Mucus Relief DM Maximum Strength 20 mg/20mL?

The NDC (National Drug Code) for Mucus Relief DM Maximum Strength 20 mg/20mL is 70000-0565, listed by Cardinal Health (Leader) 70000.

Product NDC

70000-0565

Package NDC

70000-0565-1

Other Dextromethorphan Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)